Stock listing

A2JH2F Stock Price, News, Filings & Events — Krystal Biotech, Inc.

Selected listing: A2JH2F · LSX · EUR · DE

A2JH2F:LSX is the listing for Krystal Biotech, Inc., a U.S.-based company dedicated to developing innovative gene therapies for dermatological conditions. With a market capitalization of around €10.78 billion, Krystal Biotech is focused on addressing unmet medical needs through its proprietary technology platform. The company continues to advance its research and development efforts, contributing to the evolving landscape of gene therapy. Recent news and filings highlight its commitment to bringing new treatments to market.

A2JH2F:LSXEURDEUpdated July 21, 2026
Krystal Biotech, Inc. logo
Ticker
A2JH2F:LSX
Asset type
Stock
Market cap
$10.78B
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Krystal Biotech, Inc. A2JH2F:LSX stock context

A2JH2F:LSX is the listing for Krystal Biotech, Inc., a U.S.-based company dedicated to developing innovative gene therapies for dermatological conditions. With a market capitalization of around €10.78 billion, Krystal Biotech is focused on addressing unmet medical needs through its proprietary technology platform. The company continues to advance its research and development efforts, contributing to the evolving landscape of gene therapy. Recent news and filings highlight its commitment to bringing new treatments to market.

Research Krystal Biotech, Inc.

Alternate listings